Shanghai Changzheng Hospital clinical trial pipeline

3 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 3 with minor changes only.

1. Minor

   BCMA-targeted LCAR-BCDR Cells · Relapsed/Refractory Multiple…BCMA-targeted LCAR-BCDR Cells · Relapsed/Refractory Multiple Myeloma

   Reclassified as completed (was terminated)

   Shanghai Changzheng Hospital·Phase 1· NCT05376345· Registry history of NCT05376345 on ClinicalTrials.gov (opens the registry)

   Updated Sep 22, 2026

2. Minor

   FMT-PMOS · Fecal Microbiota Transplantation for Obese…FMT-PMOS · Fecal Microbiota Transplantation for Obese · Polyendocrine Metabolic Ovarian Syndrome

   Enrollment increased: 161 → 201 participants

   Shanghai Changzheng Hospital·Not applicable· NCT07746635· Registry history of NCT07746635 on ClinicalTrials.gov (opens the registry)

   Updated Sep 22, 2026

3. Minor

   Allogeneic Regenerative Islet Transplantation · Brittle Type 1…Allogeneic Regenerative Islet Transplantation · Brittle Type 1 Diabetes Mellitus

   Registry marked status Unknown (sponsor has not verified the record since Dec 2023); last known: Recruiting

   Shanghai Changzheng Hospital·Not applicable· NCT06196996· Registry history of NCT06196996 on ClinicalTrials.gov (opens the registry)

   Changed Oct 4, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.